We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AZRX market cap is 46.58M. The company's latest EPS is USD -1.1928 and P/E is -2.27.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.09M | 0 | 0 | 0 | 0 |
| Operating Income | 4.39M | -2.28M | -4.06M | -4.18M | -3.42M |
| Net Income | 4.05M | -3.98M | -4.16M | -4.28M | -3.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 8.09M | 0 |
| Operating Income | -14.74M | -26.43M | -59.06M | -12.68M | -15.77M |
| Net Income | -15.18M | -32.67M | -58.54M | -14.97M | -16.1M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.65M | 5.44M | 5.53M | 4.33M | 5.93M |
| Total Liabilities | 6.93M | 2.7M | 2.82M | 3.45M | 2.65M |
| Total Equity | -2.28M | 2.74M | 2.71M | 881k | 3.28M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.9M | 12.92M | 11.79M | 5.44M | 6.88M |
| Total Liabilities | 4.29M | 15.57M | 19.61M | 2.7M | 3.28M |
| Total Equity | 4.62M | -2.64M | -7.82M | 2.74M | 3.6M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -16.75M | -22.34M | -2.85M | -5.61M | -8.94M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 10.22M | 15.74M | 3.55M | 5.48M | 10.87M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.03M | -11.22M | -32.29M | -22.34M | -12.38M |
| Investing | -24k | 88k | -10.32M | N/A | -500k |
| Financing | 13.15M | 17.05M | 44.76M | 15.74M | 15.23M |
| Market Cap | 46.58M |
| Price to Earnings Ratio | -2.27 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 9.85 |
| Price to Book Ratio | 10.15 |
| Dividend Yield | - |
| Shares Outstanding | 13.5M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (2.85%) |
| Company Name | AzurRx BioPharma Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.firstwavebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
